These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

128 related items for PubMed ID: 30852270

  • 1. Rapid establishment of stable retroviral packaging cells and recombinant susceptible target cell lines employing novel transposon vectors derived from Sleeping Beauty.
    Berg K, Schäfer VN, Bartnicki N, Eggenschwiler R, Cantz T, Stitz J.
    Virology; 2019 May; 531():40-47. PubMed ID: 30852270
    [Abstract] [Full Text] [Related]

  • 2. Establishment of a novel stable human suspension packaging cell line producing ecotropic retroviral MLV(PVC-211) vectors efficiently transducing murine hematopoietic stem and progenitor cells.
    van Heuvel Y, Berg K, Hirch T, Winn K, Modlich U, Stitz J.
    J Virol Methods; 2021 Nov; 297():114243. PubMed ID: 34314749
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Stable expression of the ecotropic retrovirus receptor in amphotropic packaging cells facilitates the transfer of recombinant vectors and enhances the yield of retroviral particles.
    Gerstmayer B, Groner B, Wels W, Schnierle BS.
    J Virol Methods; 1999 Aug; 81(1-2):71-5. PubMed ID: 10488763
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Packaging system for rapid production of murine leukemia virus vectors with variable tropism.
    Landau NR, Littman DR.
    J Virol; 1992 Aug; 66(8):5110-3. PubMed ID: 1321291
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. A novel human amphotropic packaging cell line: high titer, complement resistance, and improved safety.
    Rigg RJ, Chen J, Dando JS, Forestell SP, Plavec I, Böhnlein E.
    Virology; 1996 Apr 01; 218(1):290-5. PubMed ID: 8615038
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Multiple modifications allow high-titer production of retroviral vectors carrying heterologous regulatory elements.
    Hlavaty J, Stracke A, Klein D, Salmons B, Günzburg WH, Renner M.
    J Virol; 2004 Feb 01; 78(3):1384-92. PubMed ID: 14722293
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Transposon vector-mediated stable gene transfer for the accelerated establishment of recombinant mammalian cell pools allowing for high-yield production of biologics.
    Tschorn N, Berg K, Stitz J.
    Biotechnol Lett; 2020 Jul 01; 42(7):1103-1112. PubMed ID: 32323079
    [Abstract] [Full Text] [Related]

  • 18. A packaging cell line generating CD4-specific retroviral vectors for efficient gene transfer into primary human T-helper lymphocytes.
    Thaler S, Schnierle BS.
    Mol Ther; 2001 Sep 01; 4(3):273-9. PubMed ID: 11545619
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.